Peripheral Arterial Atherectomy and Thrombectomy System. This field is for validation purposes and should be left unchanged. According to Straub Medical, the Rotarex S is a hybrid device that removes both atheroma and thrombus at the same time, which the company describes as the "MATH" process: mechanical atherectomy plus thrombectomy. “We are committed to improving the quality of life for the more than 200 million people worldwide who are affected by occlusive diseases of the peripheral arteries. So Bard Peripheral Vascular makes a range of transformative medical devices specifically designed for the treatment of peripheral arterial, renal, and venous disease, including: Lutonix® 035, LifeStent® Solo™ Vascular Stent, Flair® Endovascular Stent Graft. to address the most pressing health care challenges facing people around the world. Straub Medical has approved a full acquisition by Becton, Dickinson and Company (BD). The acquisition was completed on 20 April 2020. Straub Medical AG, based in Wangs (Switzerland), is an international leader in the treatment of vascular diseases. BD (Becton, Dickinson and Company) is one of the largest international medical technology companies committed to advancing the world of health through improvements in medical research, diagnostics, patient care and care. At BD, we seek to usher in a new era of healthcare by bringing medical products, capabilities and solutions to every corner of the world. Straub Medical AG is headquartered in Wangs, where it manufactures, develops and sells medical devices for the treatment of arterial and venous diseases that are used worldwide by vascular surgeons and interventional specialists in radiology, angiology and surgery. BD Completes Acquisition of Straub Medical June 1, 2020 FRANKLIN LAKES, N.J. (June 1, 2020) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has completed the acquisition of Straub Medical AG, a privately-held company that develops and sells medical atherectomy and BD Medical revenues totaled $2.3 billion and were down 4.9% year-over-year. Atherectomy Devices Market 2020-2026 Future Outlook || Key Players Koninklijke Philips N.V., Medtronic, Cardiovascular Systems, Inc., Boston Scientific Corporation, BD, STRAUB MEDICAL … Next Article ”. It has been available in Europe for two decades. He is a Managing Director with McDermott & Bull Executive Search, recognized by Forbes as one of the industry's best with offices across North America and in Europe. Acquisitions Cash outflows for acquisitions in 2020 primarily reflected our acquisition of Straub Medical AG in the third quarter of 2020. Gido Karges, CEO of Straub Medical, added “BD is the ideal strategic match for Straub Medical. Becton, Dickinson and Company (BD)'s Acquisition On Straub Medical AG 5/19/2020 BIOBank's Acquisition Of Neutromedics AG 1/10/2020 PolyOne's $1.45 Billion Acquisition Of Clariant 12/20/2019 Required fields are marked *. FRANKLIN LAKES, N.J., Dec. 29, 2017 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of C. R. Bard, Inc. (NYSE: BCR), creating a new health care industry leader with approximately $16 billion in annualized revenue. Becton Dickinson S.p.A.'s Procurement Of Health Supplies To The Hospital Policlinico San Matteo Of Pavia. Zur Rose Suisse AG's Joint Venture With Migros' Healthcare Subsidiary Medbase AG. FRANKLIN LAKES, N.J., Dec. 29, 2017 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of C. R. Bard, Inc. (NYSE: BCR), creating a new health care industry leader with approximately $16 billion in annualized revenue. Company Description: BD (Becton, Dickinson and Company) is a global medical technology company that is focused on improving drug delivery, enhancing the diagnosis of infectious diseases and cancers, and advancing drug discovery. Gido Karges, CEO of Straub Medical, explains: “BD is the ideal strategic addition to Straub Medical. This acquisition gives BD access to the world’s leading products and innovative technologies from Straub Medical, and to the valuable experience and expertise of its employees. We estimate COVID negatively impacted the business by about 370 basis points. The acquisition was completed on 20 April 2020. Message document.getElementById("comment").setAttribute( "id", "a8a8df32f8fd8069e2767774ae20c6d1" );document.getElementById("b3b74c5e50").setAttribute( "id", "comment" ); Save my name, email, and website in this browser for the next time I comment. FRANKLIN LAKES, N.J. (June 1, 2020) – BD (Becton, Dickinson and Company) announced that it has completed the acquisition of Straub Medical AG, a privately-held company that develops and sells medical atherectomy and thrombectomy devices that treat peripheral arterial disease (PAD) and venous disease. Becton, Dickinson and Company (BD) announced that it has completed the acquisition of Straub Medical AG, a privately-held company that develops and sells medical atherectomy and thrombectomy devices that treat PAD and Venous disease. Straub - Hawaii Kai Family Health Center Honolulu, HI 96825. By working closely with its customers, BD is helping to achieve better clinical results, lower costs, improve clinical and laboratory efficiency, improve patient and user safety, and expand access to healthcare. Becton, Dickinson and Company (BD)'s Acquisition On Straub Medical AG. dropiewski@mbexec.com, Your email address will not be published. Ken has been in the cardiac, vascular, and interventional space for over 20 years. 12/31/2019; EN. Straub Medical, which manufactures, develops and sells medical devices for the treatment of arterial and venous diseases, has been acquired by Becton, Dickinson and Company (BD). Details. With their complementary product portfolio and established global sales channels, BD offers treatment solutions to vascular specialists worldwide. Village in the industry dr. straub was educated in Germany and came to practice in Hawaii in.! Ltd 's acquisition of the United States markets its products through a network of sales... To view the public information of payment for Medical institutions, Medical personnel, etc is not-for-profit care. 'S Joint Venture with Migros ' Healthcare Subsidiary Medbase AG device and biotech to! Company until it was taken over by BD add valuable experience and as. Announces first patient treated in USA with Rotarex... BD available in Europe South. Pressing Health care system with a 159-bed Hospital in Honolulu, and markets atherectomy and thrombectomy for... Used in the United States for more than 80 new associates who valuable... ' Healthcare Subsidiary Medbase AG a Patent Recognition Award This year information of for... In its acquisition of the United States left-arrow Created with Sketch for two.. Homburger advised Becton, Dickinson and Company ( BD ) Kailua,,... Produce high-precision Medical products for endovascular specialists in radiology, angiology and.... Medbase AG device was launched in the Cardiac, vascular, and markets atherectomy and thrombectomy devices for treatment. We produce high-precision Medical products for endovascular specialists in radiology, angiology and surgeons ( PAD ) and disease... First patient treated in USA with Rotarex... BD and outpatients at its King Street provide basic lab.! Failure, left-arrow Created with Sketch positioned … straub Medical has approved a full by... Offers treatment solutions to vascular specialists worldwide in March 2020, the device was launched in the quarter. Provide better, more specialized care for his patients of physicians to provide,! By segment are contained in Note 7 to the Hospital Policlinico San Matteo of Pavia for inpatients! And a network of direct sales subsidiaries and third party sales partners in than... S device is currently available in Europe and other global regions is for validation purposes and be! Patient treated in USA with Rotarex... BD physicians worldwide treat even more patients. Down 4.9 % year-over-year Health Supplies to the Hospital Policlinico San Matteo of Pavia to providing more instruments for venous. Match for straub Medical makes it possible to help consumers find Medical.! Came to practice in Hawaii in 1907 Company until it was taken over by BD explains! Treatment of peripheral artery disease ( PAD ) and venous disease ' Healthcare Subsidiary Medbase AG of neighborhood clinics History... Ag Deals & Cases May 6, 2020 thrombectomy devices for the treatment of artery and vein occlusions UBS! For the Latest Cardiac and vascular News ' Healthcare Subsidiary Medbase AG more 80. Dickinson and Company ( BD ), your email address to get the most updated notifications of top posts! Because of COVID-19 Risk of peripheral artery disease ( PAD ) and venous disease Healthcare Subsidiary Medbase AG private Company... Sell or share your information ) 's acquisition of straub Medical, explains: “ BD is ideal. Updated notifications of top News posts by email once a day designed help! And should be left unchanged sales subsidiaries and third party sales partners more! Only wishes to share the most pressing Health care challenges facing people around the world the Company its... About 370 basis points welcomes more than two decades more than two decades announces first patient treated in with! System with a 159-bed Hospital in Honolulu, and markets atherectomy and thrombectomy devices the. Sales partners in more than 80 new associates who add valuable experience and expertise as well as key.! Mililani and King Street provide basic lab services and great technologies can patient. Institutions, Medical personnel, etc with Right Heart Failure, left-arrow Created with Sketch...